RedHill Biopharma
Rob Jackson, Vice President of Marketing has a strong track record of success leading and executing new product launches and brand management across the pharmaceutical and medical device industries. Prior to joining RedHill, Mr. Jackson served in commercial leadership roles at Bioventus, most recently as the National Director of Market Access for the surgical business unit. Mr. Jackson served as Group Brand Director for the ulcerative colitis and purgative franchises at Salix Pharmaceuticals, where he led the launch of three brands in a four-year period. He also led new product launches for Vicuron Pharmaceuticals and Merck & Co.
This person is not in any offices
RedHill Biopharma
1 followers
Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal diseases.